Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Serono Rebif Approval Is First Orphan Drug Challenge Based On Efficacy

Mar 11 2002

• By The Pink Sheet

Related Content

Serono Rebif Blocked By Orphan Exclusivity, FDA Says, But Timing Is Unclear

Mar 08 1999

Biogen Avonex May 17 approval allowed under orphan regs based on lack of injection-site necrosis, FDA says.

May 20 1996

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window